310 related articles for article (PubMed ID: 25544730)
1. Human adipose-derived stem cells attenuate inflammatory bowel disease in IL-10 knockout mice.
Jung WY; Kang JH; Kim KG; Kim HS; Jang BI; Park YH; Song IH
Tissue Cell; 2015 Feb; 47(1):86-93. PubMed ID: 25544730
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse--a model mimicking inflammatory bowel disease.
Holgersen K; Kvist PH; Markholst H; Hansen AK; Holm TL
J Crohns Colitis; 2014 Feb; 8(2):147-60. PubMed ID: 23994255
[TBL] [Abstract][Full Text] [Related]
3. Human mesenchymal stem cells overexpressing the IL-33 antagonist soluble IL-1 receptor-like-1 attenuate endotoxin-induced acute lung injury.
Martínez-González I; Roca O; Masclans JR; Moreno R; Salcedo MT; Baekelandt V; Cruz MJ; Rello J; Aran JM
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):552-62. PubMed ID: 23656573
[TBL] [Abstract][Full Text] [Related]
4. Flaxseed oil and inflammation-associated bone abnormalities in interleukin-10 knockout mice.
Cohen SL; Moore AM; Ward WE
J Nutr Biochem; 2005 Jun; 16(6):368-74. PubMed ID: 15936649
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stem Cells Decrease Oxidative Stress in the Bowels of Interleukin-10 Knockout Mice.
Jung KJ; Lee GW; Park CH; Lee TJ; Kim JY; Sung EG; Kim SY; Jang BI; Song IH
Gut Liver; 2020 Jan; 14(1):100-107. PubMed ID: 31158947
[No Abstract] [Full Text] [Related]
6. Dietary β-glucan regulates the levels of inflammatory factors, inflammatory cytokines, and immunoglobulins in interleukin-10 knockout mice.
Ye MB; Bak JP; An CS; Jin HL; Kim JM; Kweon HJ; Choi DK; Park PJ; Kim YJ; Lim BO
J Med Food; 2011 May; 14(5):468-74. PubMed ID: 21434779
[TBL] [Abstract][Full Text] [Related]
7. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
[TBL] [Abstract][Full Text] [Related]
8. Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease.
Zhu Y; Mahon BD; Froicu M; Cantorna MT
Eur J Immunol; 2005 Jan; 35(1):217-24. PubMed ID: 15593122
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a novel IL-10 deficient cell transfer model for colitis.
Ikenoue Y; Tagami T; Murata M
Int Immunopharmacol; 2005 Jun; 5(6):993-1006. PubMed ID: 15829415
[TBL] [Abstract][Full Text] [Related]
10. 5-Lipoxygenase-derived lipid mediators are not required for the development of NSAID-induced inflammatory bowel disease in IL-10-/- mice.
Narushima S; DiMeo D; Tian J; Zhang J; Liu D; Berg DJ
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G477-88. PubMed ID: 18048478
[TBL] [Abstract][Full Text] [Related]
11. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease.
Hale LP; Greer PK; Trinh CT; Gottfried MR
Clin Immunol; 2005 Aug; 116(2):135-42. PubMed ID: 15936249
[TBL] [Abstract][Full Text] [Related]
12. Potential therapeutic utility of mesenchymal stem cells in inflammatory bowel disease in mice.
Abdel Salam AG; Ata HM; Salman TM; Rashed LA; Sabry D; Schaalan MF
Int Immunopharmacol; 2014 Oct; 22(2):515-21. PubMed ID: 25133649
[TBL] [Abstract][Full Text] [Related]
13. Comparison of experimental mouse models of inflammatory bowel disease.
Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic application of mesenchymal stromal cells in murine models of inflammatory bowel disease.
Gonzalez-Rey E; Delgado M
Methods Mol Biol; 2014; 1213():331-9. PubMed ID: 25173395
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.
Bamba S; Lee CY; Brittan M; Preston SL; Direkze NC; Poulsom R; Alison MR; Wright NA; Otto WR
J Pathol; 2006 Jun; 209(2):265-73. PubMed ID: 16550633
[TBL] [Abstract][Full Text] [Related]
16. [Immune response to biological therapy of inflammatory bowel diseases].
Kniazev OV; Parfenov AI; Ruchkina IN; Lazebnik LB; Sagynbaeva VÉ
Ter Arkh; 2013; 85(12):55-9. PubMed ID: 24640669
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of triptolide on interleukin-10 gene-deficient mice with colitis.
Wei X; Gong J; Zhu J; Niu L; Zhu W; Li N; Li J
Int Immunopharmacol; 2008 Dec; 8(13-14):1808-12. PubMed ID: 18804190
[TBL] [Abstract][Full Text] [Related]
18. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases.
Froicu M; Weaver V; Wynn TA; McDowell MA; Welsh JE; Cantorna MT
Mol Endocrinol; 2003 Dec; 17(12):2386-92. PubMed ID: 14500760
[TBL] [Abstract][Full Text] [Related]
19. Predictive validity and immune cell involvement in the pathogenesis of piroxicam-accelerated colitis in interleukin-10 knockout mice.
Holgersen K; Kvist PH; Hansen AK; Holm TL
Int Immunopharmacol; 2014 Jul; 21(1):137-47. PubMed ID: 24797915
[TBL] [Abstract][Full Text] [Related]
20. Measurement of cytokine mRNA expression in intestinal biopsies of cats with inflammatory enteropathy using quantitative real-time RT-PCR.
Nguyen Van N; Taglinger K; Helps CR; Tasker S; Gruffydd-Jones TJ; Day MJ
Vet Immunol Immunopathol; 2006 Oct; 113(3-4):404-14. PubMed ID: 16879876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
